Multi-drug-resistant Tuberculosis |
|
| Editor:
| Nicolao, Hardmod Carlyle |
| ISBN: | 978-613-1-68573-6 |
| Publication Date: | Jul 2010 |
| Publisher: | AV Akademikerverlag GmbH & Co. KG
|
| Book Format: | Paperback |
| List Price: | USD $49.00 |
Book Description:
|
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Multi-drug resistant tuberculosis (MDR-TB) is defined as TB that is resistant at least to isoniazid (INH) and rifampicin (RMP), the two most powerful first-line anti-TB drugs. Isolates that are multiply-resistant to any other combination of anti-TB drugs but not to INH and RMP are not classed as MDR-TB. MDR-TB develops during treatment of fully-sensitive TB...
More DescriptionPlease note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Multi-drug resistant tuberculosis (MDR-TB) is defined as TB that is resistant at least to isoniazid (INH) and rifampicin (RMP), the two most powerful first-line anti-TB drugs. Isolates that are multiply-resistant to any other combination of anti-TB drugs but not to INH and RMP are not classed as MDR-TB. MDR-TB develops during treatment of fully-sensitive TB when the course of antibiotics is interrupted and the levels of drug in the body are insufficient to kill 100% of bacteria. This can happen for a number of reasons: patients may feel better and halt their antibiotic course, drug supplies may run out or become scarce, or patients may forget to take their medication from time to time. MDR-TB is spread from person to person as readily as drug-sensitive TB and in the same manner.